Renal Disease
📧 Sign up to get email alerts when something new happens for Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Vitamin K2 Supplementation and Vascular Calcification [Phase 4]
Phase 4 clinical trial evaluating vitamin K2 supplementation on vascular calcification in renal disease patients has been completed.
-
FDA approval · 2020-05-04FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Torsemide from Rising Pharma Holdings, Inc. under an ANDA (ANDA078249).
-
FDA approval · 2020-04-06FDA Approved: BUMETANIDE — Supplemental Application (NorthStar Rx, LLC)
The FDA approved a supplemental application for bumetanide submitted by NorthStar Rx, LLC.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress [Phase 1, Phase 2]
Clinical trial exploring the effects of immunosuppressant mycophenolate mofetil (MMF) on urinary sodium excretion response to mental stress …
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction [Phase 4]
Phase 4 trial comparing low-dose ticagrelor to low-dose prasugrel in patients with prior myocardial infarction; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Evaluation of Nail Fold Microcirculation in CKD [Phase 4]
Phase 4 clinical trial update evaluating nail fold microcirculation in chronic renal disease.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: The Lighthouse Tenofovir Cohort Study
An update on the Lighthouse Tenofovir Cohort Study investigating effects in chronic renal disease; the current status of the trial is unknow…
-
FDA approval · 2017-10-18FDA Approved: BUMETANIDE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's original application for bumetanide, granting approval of a generic bumetanide product.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: World Trade Center (WTC) RENAL
A completed study update for the World Trade Center Renal trial led by Icahn School of Medicine at Mount Sinai; the snippet does not report …
-
FDA approval · 2017-07-14FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc. The notice confirms regulatory approval o…
-
CLINICAL_TRIALS research · 2017-04-18Clinical Trial Update: Effectiveness of Point of Care Blood Analysis Obtained From Skin Puncture Blood
A clinical trial update evaluating the effectiveness of point-of-care blood analysis obtained from skin puncture samples across multiple con…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance
Completed clinical trial update evaluating a two-point iohexol plasma disappearance method to measure glomerular filtration rate.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Effect of Deep BLock on Intraoperative Surgical Conditions [Phase 4]
A Phase 4 trial evaluating the effect of Deep Block on intraoperative surgical conditions has completed, with results posted.
-
FDA approval · 2016-07-20FDA Approved: FUROSEMIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for furosemide, authorizing a generic version of this diuretic.
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF) [Phase 3]
A Phase 3 clinical trial comparing Dotarem (gadoterate meglumine) to Time-Of-Flight imaging for renal magnetic resonance angiography was ter…
-
FDA approval · 2016-03-04FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Comparison of Low Versus Normal Pressure Pneumoperitoneum - With Profound Low Versus Normal Pressure Pneumoperitoneum -With Profound Muscle Relaxation- During Laparoscopic Donor Nephrectomy [NA]
The trial compares low vs normal pressure pneumoperitoneum, with and without profound muscle relaxation, during laparoscopic donor nephrecto…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Transvaginal NOTES Nephrectomy Versus Conventional Laparoscopic Nephrectomy [NA]
This document provides an update on a clinical trial comparing transvaginal NOTES nephrectomy with conventional laparoscopic nephrectomy; th…
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Oxygen Desaturation During Hemodialysis
A clinical trial evaluating oxygen desaturation during hemodialysis sponsored by the Renal Research Institute has completed, involving renal…
-
FDA approval · 2014-10-20FDA Approved: BUMETANIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for bumetanide from Sandoz Inc.
-
FDA approval · 2014-08-26FDA Approved: FUROSEMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved Heritage Pharmaceuticals' generic furosemide (ANDA 203428) for edema-related indications and hypertension, enabling a generic v…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Dyslipidemia-related Risk Factors in Dialysis
Completed clinical trial assessing dyslipidemia-related risk factors in patients on dialysis.
-
FDA approval · 2014-01-27FDA Approved: FUROSEMIDE — Original Application (Civica, Inc.)
FDA approves Civica, Inc.’s original application for furosemide (generic diuretic).
-
CLINICAL_TRIALS other · 2013-04-30Clinical Trial Update: Care Transitions in Renal Disease Patients
Clinical trial update for a study on care transitions in renal disease patients; the current status is UNKNOWN.
-
FDA approval · 2012-03-27FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.